TPOR (phospho-Tyr626) rabbit pAb
In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages. In 1992 the human homologue, named, c-mpl, was cloned. Sequence data revealed that c-mpl encoded a protein that was homologous with members of the hematopoietic receptor superfamily. Presence of anti-sense oligodeoxynucleotides of c-mpl inhibited megakaryocyte colony formation. The ligand for c-mpl, thrombopoietin, was cloned in 1994. Thrombopoietin was shown to be the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular Cytokine receptor domains and two intracellular Cytokine receptor box motifs . TPO-R deficient mice were severely thrombocytopenic, emphasizing the important
Product Specifications
Background
UniProt
P40238
Swiss Prot
P40238
Reactivity
Human; Rat; Mouse
Immunogen
Synthesized phosho peptide around human TPOR (Tyr626)
Clonality
Polyclonal
Source
Rabbit
Applications
WB
Concentration
1 mg/ml
Dilution
WB 1:1000-2000
Molecular Weight
69,40kD
Storage Conditions
-20°C/1 year
Observed Molecular Weight
69,40kD
Fragment
IgG
Subcellular Location
Cell membrane ; Single-pass type I membrane protein. Golgi apparatus . Cell surface .
Other Product Names
Thrombopoietin receptor (TPO-R) (Myeloproliferative leukemia protein) (Proto-oncogene c-Mpl) (CD antigen CD110)
Gene ID (Human)
4352
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items